For Professional Investors Only
ContactProviding international & UK investors
with investment opportunities in fast
growing companies, each with the
opportunity to grow internationally.
Supporting ambitious companies
Barcapel Equity was established to provide international and UK investors with a professional investment opportunity into companies likely to have received seed funding, now demonstrating traction and having the basis of a strong management team which – with the right blend of skills, equity and debt – provide excellent return prospects. Barcapel Equity provides equity funding across opportunities in science and technology. We invest into and proactively support scale-up and development of ambitious companies with strong growth potential. Our focus is on UK registered companies that have an opportunity to internationalise rapidly and that are preparing for that expansion. We look to maximise our fund performance through taking a close supporting role with each investee company. Our highly experienced global team and our extensive resource portfolio ensure we have access to the skills required to fill gaps identified within our investee companies.
- Technology
- Lifesciences and Biotechnology
- Renewables
- Energy Efficiency
- Digital Health
- Data & AI
- Fintech
Negotiating and structuring investments
to enhance and accelerate prospects for substantial capital gain
- Robust due diligence processes
- Expert investment committee
- Growth capital
- Market proven business models
- Streamlined reporting tools
- Management buy-outs or buy-ins
- Cash-out deals
- Incentivise management to grow and value the business
- Mitigate risk
- Enable Barcapel Equity to achieve liquidity/exit events
What investee companies offer
- A well-balanced management team with strong leadership
- Ambitious international growth aspirations
- Healthy traction and revenues and/or technology development/IP
- The potential for 100% earnings growth over a 3-year period
- Target valuation increase of 10x over a 5-year period
- A realistic and clear opportunity for liquidity/exit
Improving Investor Returns
By enabling each investee company with both access to funding and with a company growth consultant, we aim to maximise performance, leading to higher overall Fund performance and investor DPI. Growth company consultancy services include:
Strategic Planning
Business Development
Finance Support
Follow-On Funding
Sales & Marketing Support
Technology Support
Contact Us
To participate in the Fund, you will need to complete an application form. Before an application can be accepted, the Fund Manager will first assess the eligibility of potential investors. By contacting Barcapel Equity, an applicant acknowledges that they may be required to provide evidence that they qualify as an investor.
By completing this form, you acknowledge that you have read and understood this disclaimer.
Apply for our Investment Memorandum
To receive a copy of our Summary Fund Presentation, Investment Memorandum and supporting documents, please complete the contact form. For compliance purposes, one of our Senior Fund Managers will contact you directly to take you through the process within two working days of receipt of your request.
Our Team
Key Executives
A P Haas
Chairman & Senior Partner
Athol has built companies across several sectors from the ground up and worked as a consultant to several others. He has experience of successful exits by trade sale and management buy- out. Alongside senior roles in technology and life sciences, over the past decade, he has built up a portfolio of family office investments valued at several £M in sectors as diverse as creative, defence, recruitment and software apps. Athol’s investee companies have raised over £35M in equity and non-diluted funding in UK, GCC and Asian markets. With many speaking credits and awards, Athol has a level of senior experience which is invaluable when identifying, assessing and managing businesses to successful liquidity events.
Stuart Gilmore
Managing Partner
Stuart has worked with companies across several sectors, firstly through his career in commercial and corporate banking and more recently through his involvement as a partner in an early-stage company investment fund. He has been closely involved with renewable energy investments – particularly hydro, onshore wind, solar and biogas. Stuart has an extensive business network which delivers a flow of quality investment opportunities. He has a deep understanding of issues facing start-up and early-stage businesses, acting as a NED and mentor to several. He has significant business experience covering business growth, takeovers, management buy-outs and buy-ins. Stuart is a Member of the Chartered Institute of Bankers in Scotland and holds a MA(Hons) in Geography from the University of Edinburgh.
John Livingstone
Head of Portfolio Management
Currently residing in Abu Dhabi, John began his career on the Interest Rates Swaps desk in the early 90’s. Spending the subsequent 20 years working for large blue-chip Asset Managers including Aberdeen Asset Management, RBS Asset Management and Henderson Global Advisors, John’s experience extends to long only and alternative investment asset classes. More recently, John ran three different funds and outperformed his peer group in 8 of 10 years. Each fund incorporated equities, bonds, currency, investing in other hedge funds, long only funds and emerging technology private equity. John holds an MA in Economics and Politics and an MSc in Investment Analysis both from the University of Stirling and he is an associate member of the CFA (UK), an Associate of the Society of Investment Professionals and a graduate of the INSEAD Leadership Development Programme.
Fraser Niven
Chief Financial Officer
Fraser is a commercially aware Chartered Accountant with significant experience gained in financial and general management roles following his training and qualifying with Touche Ross (now Deloitte) over 30 years ago. His career developed with his keen knowledge and instinct for the financial management of business with Board appointments in a variety of sectors including hospitality, mining and retail. Latterly he was appointed Chief Executive of Hamilton and Kinneil Estates in 2002. During this time, he was responsible for all commercial interests of the Duke of Hamilton and His Family including the diversification of Estate activities. The diversification included investing in start-up companies; he set up and coordinated a Business Angel syndicate that successfully invested in a number of companies, leading to him serving on various boards as Investor Director on behalf of his fellow investors. He is non-Executive Director of several companies covering a broad range of industries which continue to enhance his knowledge and experience and participates in an Angel syndicate, Apollo Investors. As a Director of No.9 Corporate Advisers he offers strategic planning, financial and overall commercial management services to developing businesses or those requiring turnaround experience.
Key Advisors to the Investment Advisor
Martin Bell
Family Business, Re-Structuring, Leadership
After studying a BSc in Agriculture at Aberdeen and a MSc in Economics at the University of London, Martin was Operations Director of a coffee trading and processing business in Kinshasa (DRC) before setting up a successful pizza manufacturing company, Uin Foods Limited.
Now Managing Director of the Castle View Group since 2000 Martin re-structured, grew and drove the Group forward. He successfully moved direction from the catering sector into leisure, paid down debt and built a profitable trading Group set to break £250 m turnover with a £15m net profit this year with over 8000 employees.
Martin has been involved a non-executive role within the SWP Group plc since 2008 and took this off Aim in 2017 as well as undertaking a new role as Chairman of Novosound and being involved in various similar activities such as an Angel Investor.
Martin’s hobbies include golf, tennis, music and languages.
Richard Cooper
Operations, Sales Growth
Richard is a highly experienced operations professional with a career that includes Howden Group, Hyster, Rolls Royce and General Electric. He was a co-founder of Cascade Technologies which was sold to Emerson Electric for a substantial sum, allowing him to spread his experience into helping develop younger companies within the medical devices, gas analysis and ultrasound technology industries. Richard is currently CEO of an ultrasound company with global ambition and NED to several other companies with angel syndicate backing. Richard has an honours degree in Production Engineering and Management from the University of Strathclyde, a post graduate qualification in Process Plant from the University of the West of Scotland and has been a Chartered Engineer (C.Eng) since 1982.
Joanna Livingstone
Project Management, Business Systems Analysis, Sovereign Wealth
Joanna has 14 years of work experience in Information Technology within both the Telecoms and Financial Sectors. Having completed a MSc in Economics in Szczecin, and a MSc. in Business Systems Analysis and Design at the University of London, her focus has been in managing software development and delivery, as well as talent development. Currently Joanna works in Portfolio and Project Management function for a Sovereign Wealth Fund.
Adrian Louden
Scaling, Acquisitions, Strategy
Based in Scotland, Adrian is an experienced large family business owner and CEO. He built Scotch Frost of Glasgow Ltd - a multi-site food distribution business - to a turnover of circa £60m and led its substantial sale to a Japanese Food Co-Operative. Since exiting, Adrian acts as a NED/Chairman across the UK private sector and is currently Chair of the YPO Scotland Chapter, a significant, global chief executive leadership organisation and a Fellow of the Institute of Directors. Adrian has a deep understanding of managing currency and currency hedging products, banking instruments and the shipping processes for import/export of food products.
Dr Karen J. Williams
Specialist Consulting, Clinical Research (Oncology)
Karen is a globally recognised expert in her field of oncology research and clinical trials. As founder and CEO of Glasgow, Delaware and Dublin headquartered Karma Oncology, Karen utilises decades of experience with Boehringer Mannheim, Novartis and Pfizer to provide niche clinical development services. Karen adds an in-depth understanding of the global life sciences marketplace which is an invaluable resource when assessing science-based opportunities. She holds an honours degree in Biology and a PhD in bioengineering, both from the University of Strathclyde. Karen can also boast a series of professional qualifications demonstrating her suitability as an expert in field of life sciences.
Key Professional Partners
Find Us
Barcapel Equity
Kemp House
160 City Road
London
EC1V 2NX
United Kingdom
